CX3CR1 and Alzheimer disease: Although unravelling the drivers of the decreased phagocytic capacity of microglia in AD is beyond the scope of the present study, we sought to determine the expression levels of CX3CR1 ligand, namely the neuronal cytokine CX3CL1, at various Braak-Tau stages.